Tag Archive for: ETH Zurich

Posts

Licensing Agreement with ETH Zurich on LRC technoloy

Dualsystems Biotech closes Licensing Agreement with ETH Zurich on Ligand Receptor Capture (LRC) technology Dualsystems Biotech has licensed an innovative technology to discover cell-surface receptors for a vast range of ligands of interest. LRC is centered around an innovative trifunctional chemoproteomic reagent named TriCEPS, which enables the unbiased identification of cell surface receptors for many…

DO YOU WANT TO TEST IT NOW?

Transport not incl. Your Information will never be shared with any third party.

To get pretest TriCEPS Material please contact us!

Identify the targets of your ligand on the living cells. Prior to the main experiment get free TriCEPS Material to test the functionality of your TriCEPS coupled ligand.

Extracellular proteins
Peptide ligands
Antibodies
Engineered affinity binders
Viruses

YES!

DO YOU WANT TO TALK TO US?

Your information will never be shared with any third party.

LRC-TriCEPS to identify targets on the surface of living cells.

Please provide your email address and we will contact you to arrange a call.

Small molecules
Extracellular proteins
Peptide ligands
Antibodies
Engineered affinity binders
Viruses

YES!

Posts

Licensing Agreement with ETH Zurich on LRC technoloy

Dualsystems Biotech AG

LRC-TriCEPS Video

Subscribe to our LRC-TriCEPS Newsletter